SCHEMBL8957393

SCHEMBL8957393

CC(C)(CO[N+](=O)[O-])c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.44
ALDH1A1 P00352 5/20 0.43
MAPK1 P28482 1/20 0.38
ESR2 Q92731 2/20 0.37
CYP2C19 P33261 1/20 0.36
HIF1A Q16665 1/20 0.36
ALOX15 P16050 1/20 0.35
GSR P00390 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
LMNA P02545 1/20 0.34
HTT P42858 1/20 0.34
KMT2A Q03164 2/20 0.34
MAPT P10636 1/20 0.33
BCHE P06276 2/20 0.33
ACHE P22303 2/20 0.33
PTGS1 P23219 1/20 0.33
PTGS2 P35354 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8957402 0.82 GRIN2D (0.49) ALDH1A1CYP2C19NPSR1LMNAKMT2A
SCHEMBL9803859 0.76 ALDH1A1 (0.42) ALDH1A1ESR2GSRLMNA
SCHEMBL42638 0.75 TAAR1 (0.58) TAAR1ALDH1A1MAPK1ESR2CYP2C19
SCHEMBL10950133 0.75 TAAR1 (0.48) TAAR1ALDH1A1MAPK1CYP2C19HIF1A
SCHEMBL9508355 0.73 TAAR1 (0.56) TAAR1ALDH1A1MAPK1ESR2CYP2C19
SCHEMBL15863039 0.72 TAAR1 (0.45) TAAR1ALDH1A1MAPK1ESR2CYP2C19
Nitric Acid SCHEMBL9873795 0.72 TAAR1 (0.45) TAAR1ALDH1A1MAPK1ESR2CYP2C19
SCHEMBL8278933 0.71 TAAR1 (0.54) TAAR1ALDH1A1MAPK1ESR2CYP2C19
SCHEMBL28688799 0.71 MAPK1 (0.52) TAAR1ALDH1A1MAPK1ESR2CYP2C19
SCHEMBL109031 0.70 TAAR1 (0.52) TAAR1ALDH1A1MAPK1ESR2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0689435-A1 USE OF SUBSTITUTED ALKYL NITRATES FOR THE TREATMENT OF PATHOLOGICALLY INCREASED INTRA-OCULAR PRESSURE BYK NEDERLAND BV (NL) 1996-01-03 EP claimed
WO-1994021248-A1 USE OF SUBSTITUTED ALKYL NITRATES FOR THE TREATMENT OF PATHOLOGICALLY INCREASED INTRA-OCULAR PRESSURE BYK NEDERLAND BV (NL) 1994-09-29 WO claimed
US-5049694-A Cardiovascular disorders CEDONA PHARMACEUTICALS B.V. (NL) 1991-09-17 US disclosed
EP-0359335-A2 Pharmaceutical composition having relaxing activity which contains a nitrate ester as active substance CEDONA PHARMACEUTICALS B.V. (NL) 1990-03-21 EP disclosed